Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phuong Dang

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Haematologica|December 31, 2011
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinibDeborah L White, Jerald Radich, Simona Soverini, et al.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
Cancer Letters|September 4, 2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsTeresa Sadras, Susan L Heatley, Chung H Kok, et al.
Journal of Ethnopharmacology|July 5, 2021
Linh Phu Khang Tue Tinh inhibited prostate proliferation in rats induced benign prostatic hyperplasia by testosterone propionateThuy Doan Minh, Tuan Nguyen Thanh Ha, Thuan Nguyen Duy, et al.
Neurosurgical Focus|August 1, 2021
Real-time navigation guidance with intraoperative CT imaging for pedicle screw placement using an augmented reality head-mounted display: a proof-of-concept studyDaniel S Yanni, Burak M Ozgur, Robert G Louis, et al.
Blood|August 24, 2023
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapyIlaria S Pagani, Naranie Shanmuganathan, Phuong Dang, et al.
Molecular Genetics & Genomic Medicine|August 7, 2023
In silico validation revealed the role of SCN5A mutations and their genotype-phenotype correlations in Brugada syndromeHung Manh Pham, Duy Phuong Dang, Thanh Dat Ta, et al.
Leukemia|November 27, 2019
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S Pagani, Phuong Dang, Verity A Saunders, et al.
Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Micropublication Biology|June 24, 2026
Functional Annotation of FD Cluster Phage Bouclier that Infects <i>Arthrobacter globiformis</i>Matias Espinosa, Hannah Atchley, Kaden K Bambach, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Haematologica|December 31, 2011
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinibDeborah L White, Jerald Radich, Simona Soverini, et al.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
Cancer Letters|September 4, 2017
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsTeresa Sadras, Susan L Heatley, Chung H Kok, et al.
Journal of Ethnopharmacology|July 5, 2021
Linh Phu Khang Tue Tinh inhibited prostate proliferation in rats induced benign prostatic hyperplasia by testosterone propionateThuy Doan Minh, Tuan Nguyen Thanh Ha, Thuan Nguyen Duy, et al.
Neurosurgical Focus|August 1, 2021
Real-time navigation guidance with intraoperative CT imaging for pedicle screw placement using an augmented reality head-mounted display: a proof-of-concept studyDaniel S Yanni, Burak M Ozgur, Robert G Louis, et al.
Blood|August 24, 2023
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapyIlaria S Pagani, Naranie Shanmuganathan, Phuong Dang, et al.
Molecular Genetics & Genomic Medicine|August 7, 2023
In silico validation revealed the role of SCN5A mutations and their genotype-phenotype correlations in Brugada syndromeHung Manh Pham, Duy Phuong Dang, Thanh Dat Ta, et al.
Leukemia|November 27, 2019
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S Pagani, Phuong Dang, Verity A Saunders, et al.
Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Micropublication Biology|June 24, 2026
Functional Annotation of FD Cluster Phage Bouclier that Infects <i>Arthrobacter globiformis</i>Matias Espinosa, Hannah Atchley, Kaden K Bambach, et al.
Pageof 7